Login/Register

UCT III Plus Technology

Taiwan
Introduction
HealthBanks Biomedical is the pioneer for Umbilical Cord Tissue Cryopreservation (patented UCT Technology) which was introduced via AABB journal in 2016. We have successfully developed UCT III Plus Technology which preserved therapeutic properties of MSCs for regenerative medicine. Also, the vascular cells from UCT III Plus cryopreserved umbilical cord (UC) may retain the normal cellular cryopreservation, further MSC and vascular cell therapy ap-plications.
Features / strengths
Patented UCT Technology
One Cord Tissue = Many kinds of cells = Many Patients
Single source material
Driving more clinical indications and potential
Specification in detail
UCT Cryopreservation
Unit

Information
Introduction
HealthBanks Biomedical is the pioneer for Umbilical Cord Tissue Cryopreservation (patented UCT Technology) which was introduced via AABB journal in 2016. We have successfully developed UCT III Plus Technology which preserved therapeutic properties of MSCs for regenerative medicine. Also, the vascular cells from UCT III Plus cryopreserved umbilical cord (UC) may retain the normal cellular cryopreservation, further MSC and vascular cell therapy ap-plications.
Features / strengths
Patented UCT Technology
One Cord Tissue = Many kinds of cells = Many Patients
Single source material
Driving more clinical indications and potential
Specification in detail
UCT Cryopreservation
Unit

UCT III Plus Technology

Taiwan
HealthBanks Biomedical Co., Ltd Other products
Recommended